Drug Trial Radar · NCT06776432
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Actual
Start
Apr 2, 2025
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Jan 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.
Conditions
- Sleep Apnea
Interventions
SivopixantDrug
Administered as specified in the treatment arm
PlaceboDrug
Administered as specified in the treatment arm.
AcetazolamideDrug
Administered as specified in the treatment arm
SASS-001Drug
Administered as specified in the treatment arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Endpoint - Change in apnea-hypopnea index (SASS-001 arm vs baseline at Visit 7 polysomnography). Scale is minimum -60 to max 60. Lower scores mean improvement from baseline.Time frame: up to 6 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California
Teradan Clinical Trials
Brandon, Florida
PharmaDev Clinical Research Institute, LLC
Miami, Florida
Infinity Medical Research
North Dartmouth, Massachusetts
John D. Dingell VA Medical Center
Detroit, Michigan
Mayo Clinic
Rochester, Minnesota
Intrepid Research, LLC
Cincinnati, Ohio
OnSite Clinical Solutions
Rock Hill, South Carolina
Huntsville Research Institute LLC
Huntsville, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.